RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research, profile.
Open | $3.42 |
Close | $3.57 |
Volume / Avg. | 271.74K / 691.46K |
Day Range | 3.37 - 3.62 |
52 Wk Range | 2.61 - 27.35 |
Market Cap | $124.26M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 12.52% |
Days to Cover | 6.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of RAPT Therapeutics (NASDAQ:RAPT) through any online brokerage.
Other companies in RAPT Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), Vistagen Therapeutics (NASDAQ:VTGN) and Tevogen Bio Holdings (NASDAQ:TVGN).
There is no analysis for RAPT Therapeutics.
RAPT Therapeutics has a consensus price target of $29.83.
The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $3.56 last updated July 15, 2024 at 5:04 PM EDT.
There are no upcoming dividends for RAPT Therapeutics.
RAPT Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for RAPT Therapeutics.
RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.